China at a glance
- Population
- 1.41 billion 2025
- Life expectancy at birth
- 78.0 years, 2024
- People aged 65 and over
- 14.9 % of people, 2025
- Health spending per person
- 763 US$ per person, 2023
- Doctors
- 3.11 per 1,000 people, 2022
Updated
Reviewed by Vidhi Upadhyay
China Traditional Chinese Medicine Market Industry Trends and Forecast to 2034: Segmented by (Product, Channel, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$13.13 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $11.55 Bn | — | — |
| 2025 (base) | $12.51 Bn | +$958.9 Mn | — |
| 2026 (forecast) | $13.55 Bn | +$1.04 Bn | +8.3% |
| 2027 (forecast) | $14.68 Bn | +$1.12 Bn | +17.3% |
| 2028 (forecast) | $15.89 Bn | +$1.22 Bn | +27% |
| 2029 (forecast) | $17.21 Bn | +$1.32 Bn | +37.6% |
| 2030 (forecast) | $18.64 Bn | +$1.43 Bn | +49% |
| 2031 (forecast) | $20.19 Bn | +$1.55 Bn | +61.4% |
| 2032 (forecast) | $21.86 Bn | +$1.68 Bn | +74.7% |
| 2033 (forecast) | $23.68 Bn | +$1.81 Bn | +89.2% |
| 2034 (forecast) | $25.64 Bn | +$1.97 Bn | +105% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $12.51 Bn placeholder estimate |
|---|---|
| Forecast, 2034 | $25.64 Bn placeholder estimate |
| Growth (CAGR), 2025–2034 | 8.3% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Product, channel and end user (see all) |
| Key players | Tongrentang, Yunnan Baiyao, Tasly Pharmaceutical, China Resources Sanjiu, Tsumura (see all) |
| Regulator in China | NMPASource: National Medical Products Administration. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Traditional Chinese medicine includes herbal remedies, acupuncture and other practices used for prevention and treatment.
Key segments of the traditional Chinese Medicine market include product (Herbal Medicines, Patent Medicines and Acupuncture Services) and channel (Hospitals, Pharmacies and Online).
Rising incomes, fast-growing private hospital chains, medical tourism, government health reforms and a young, digital-first population are driving the traditional Chinese Medicine market.
Public-private partnerships, digital health and growing middle classes in Asia, the Middle East, Africa and Latin America give the traditional Chinese Medicine market strong room to grow.
Uneven quality standards, limited insurance coverage, high out-of-pocket costs and regulatory differences between countries hold back the traditional Chinese Medicine market.
The traditional Chinese Medicine market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Drugs need approval from the National Medical Products Administration (NMPA) before sale.[1] Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List.[2]
[1] National Medical Products Administration. Checked 14 Nov 2026.
[2] National Healthcare Security Administration. Checked 14 Nov 2026.
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for traditional Chinese Medicine. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in China.
What doctors and scientists are doing in Traditional Chinese Medicine right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.
From our blog
China · 2 shared keywords
China · 1 shared keyword
China · 1 shared keyword
China · 1 shared keyword
China · 1 shared keyword
China · 1 shared keyword
OTC & Nutraceuticals · China
OTC & Nutraceuticals · China
OTC & Nutraceuticals · China
OTC & Nutraceuticals · China
OTC & Nutraceuticals · China
OTC & Nutraceuticals · China